RenovoRx Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $422.00K Beat $329.67K Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8.05 percent. This is a 20 percent increase over losses of $(0.10) per share from the same
RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8.05 percent. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $422.00 thousand which beat the analyst consensus estimate of $329.67 thousand by 28.01 percent.